Dr. Sutirtha Mukhopadhyay is a seasoned physician with over 15 years of experience in pharmacovigilance and medical monitoring across multiple therapeutic areas. He has a robust background in developing and implementing risk management strategies to ensure patient safety and compliance. Dr. Mukhopadhyay has successfully managed diverse pharmacovigilance teams and has extensive experience in clinical trials, including setting up Phase II and Phase III oncology trials. He is currently working for Boehringer-Ingelheim as Senior Patient Safety Physician. He has held various positions at Sanofi, Ablynx, AB Science, Parexel, ICON, and Max Neeman. Dr. Mukhopadhyay holds an M.B.B.S., a Post Graduate Diploma in Clinical Research and Pharmacovigilance, and an MBA in Pharmaceutical Management. He has also completed various certifications, including in Immuno-Oncology, Safety Risk Management and Artificial Intelligence. His work has been published in several reputable journals, highlighting his contributions to the field.